GNMX
Bank of America’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-26,739
| Closed | -$4K | – | 6604 |
|
2019
Q4 | $4K | Buy |
26,739
+25,739
| +2,574% | +$3.85K | ﹤0.01% | 5975 |
|
2019
Q3 | $0 | Sell |
1,000
-3,365
| -77% | – | ﹤0.01% | 6697 |
|
2019
Q2 | $1K | Buy |
4,365
+3,365
| +337% | +$771 | ﹤0.01% | 6325 |
|
2019
Q1 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 6590 |
|
2018
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 6253 |
|
2018
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 6436 |
|
2018
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 6271 |
|
2018
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 6167 |
|
2017
Q4 | $1K | Sell |
1,000
-911
| -48% | -$911 | ﹤0.01% | 6130 |
|
2017
Q3 | $2K | Sell |
1,911
-7,519
| -80% | -$7.87K | ﹤0.01% | 6079 |
|
2017
Q2 | $13K | Buy |
9,430
+2,615
| +38% | +$3.61K | ﹤0.01% | 5590 |
|
2017
Q1 | $13K | Buy |
6,815
+1,031
| +18% | +$1.97K | ﹤0.01% | 5715 |
|
2016
Q4 | $30K | Buy |
5,784
+3,574
| +162% | +$18.5K | ﹤0.01% | 5390 |
|
2016
Q3 | $12K | Sell |
2,210
-731
| -25% | -$3.97K | ﹤0.01% | 5560 |
|
2016
Q2 | $16K | Buy |
2,941
+1,941
| +194% | +$10.6K | ﹤0.01% | 5533 |
|
2016
Q1 | $4K | Sell |
1,000
-2,537
| -72% | -$10.1K | ﹤0.01% | 5818 |
|
2015
Q4 | $21K | Buy |
3,537
+3,324
| +1,561% | +$19.7K | ﹤0.01% | 5413 |
|
2015
Q3 | $2K | Sell |
213
-247
| -54% | -$2.32K | ﹤0.01% | 5929 |
|
2015
Q2 | $3K | Buy |
+460
| New | +$3K | ﹤0.01% | 5938 |
|
2014
Q1 | – | Sell |
-51
| Closed | – | – | 6153 |
|
2013
Q4 | $0 | Buy |
+51
| New | – | ﹤0.01% | 6229 |
|
2013
Q3 | – | Sell |
-108
| Closed | – | – | 6132 |
|
2013
Q2 | $0 | Buy |
+108
| New | – | ﹤0.01% | 6048 |
|